Key considerations for phosphatidylserine quantification by 31P NMR in pharmaceutical analysis

Daniela Rebollar-Ramos, Shao-Nong Chen, David C. Lankin, Robert A. Kleps, Guido F. Pauli

Open source

DOI
10.1016/j.jpba.2025.117248
Published
2026-03
Container
Journal of Pharmaceutical and Biomedical Analysis
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpba.2025.117248,
  title = {Key considerations for phosphatidylserine quantification by 31P NMR in pharmaceutical analysis},
  author = {Daniela Rebollar-Ramos and Shao-Nong Chen and David C. Lankin and Robert A. Kleps and Guido F. Pauli},
  year = {2026},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  doi = {10.1016/j.jpba.2025.117248},
  url = {https://doi.org/10.1016/j.jpba.2025.117248}
}

RIS

TY  - JOUR
TI  - Key considerations for phosphatidylserine quantification by 31P NMR in pharmaceutical analysis
AU  - Daniela Rebollar-Ramos
AU  - Shao-Nong Chen
AU  - David C. Lankin
AU  - Robert A. Kleps
AU  - Guido F. Pauli
PY  - 2026
JO  - Journal of Pharmaceutical and Biomedical Analysis
DO  - 10.1016/j.jpba.2025.117248
UR  - https://doi.org/10.1016/j.jpba.2025.117248
ER  - 

APA

Rebollar-Ramos, D., Chen, S., Lankin, D. C., Kleps, R. A., & Pauli, G. F. (2026). Key considerations for phosphatidylserine quantification by 31P NMR in pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.117248

Source records